Expertise in
13
conditions

Birgit Burkhardt

Muenster, NW, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
13
conditions
Muenster, NW, DE 
OverviewLocationsClinical Research

Overview

Birgit Burkhardt practices in Muenster, Germany. Ms. Burkhardt is highly rated in 13 conditions, according to our data. Her top areas of expertise are Burkitt Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant.

Her clinical research consists of co-authoring 142 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Muenster, NW, Germany
Other Locations
Munich, BY, Germany
Berlin, BE, Germany
Germany
Karlsruhe, BW 76131, Germany
Giessen, HE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Enrollment Status: Recruiting
Publish Date: January 16, 2024
Intervention Type: Drug, Radiation
Study Drugs: VP16, Thiotepa, Treosulfan, Fludarabine, Busulfan, Anti-Thymocyte Globulin, Cyclophosphamide, Grafalon
Study Phase: Phase 2/Phase 3
B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
Enrollment Status: Active_not_recruiting
Publish Date: March 24, 2025
Intervention Type: Drug
Study Drugs: Rituximab, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide, Methotrexate, Prednisolone, Vincristine
Study Phase: Phase 3
Clinical Phase II Trial to Describe the Safety and Efficacy of Treosulfan-based Conditioning Therapy Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Paediatric Patients With Haematological Malignancies
Clinical Phase II Trial to Describe the Safety and Efficacy of Treosulfan-based Conditioning Therapy Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Paediatric Patients With Haematological Malignancies
Enrollment Status: Completed
Publish Date: May 04, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trial

141 Total Publications

Extramedullary plasmacytoma in children is a genetically distinct localized neoplasia curable by surgical resection.
Extramedullary plasmacytoma in children is a genetically distinct localized neoplasia curable by surgical resection.
Journal: Blood advances
Published: March 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Burkhardt's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 29 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile